Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 30

    1.

    Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water.

    Marshall G, Ferreccio C, Yuan Y, Bates MN, Steinmaus C, Selvin S, Liaw J, Smith AH.

    J Natl Cancer Inst. 2007 Jun 20;99(12):920-8. Epub 2007 Jun 12.PMID: 17565158 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Transplacental arsenic carcinogenesis in mice.

    Waalkes MP, Liu J, Diwan BA.

    Toxicol Appl Pharmacol. 2007 Aug 1;222(3):271-80. Epub 2007 Jan 12.PMID: 17306315 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Association of arsenic-contaminated drinking-water with prevalence of skin cancer in Wisconsin's Fox River Valley.

    Knobeloch LM, Zierold KM, Anderson HA.

    J Health Popul Nutr. 2006 Jun;24(2):206-13.PMID: 17195561 [PubMed - indexed for MEDLINE]Related articles

    4.

    Arsenic-induced bladder cancer in an animal model.

    Cohen SM, Ohnishi T, Arnold LL, Le XC.

    Toxicol Appl Pharmacol. 2007 Aug 1;222(3):258-63. Epub 2006 Oct 17. Review.PMID: 17109909 [PubMed - indexed for MEDLINE]Related articles

    5.

    Arsenic, mode of action at biologically plausible low doses: what are the implications for low dose cancer risk?

    Snow ET, Sykora P, Durham TR, Klein CB.

    Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):557-64. Review.PMID: 15996700 [PubMed - indexed for MEDLINE]Related articles

    6.

    Evidence that arsenite acts as a cocarcinogen in skin cancer.

    Rossman TG, Uddin AN, Burns FJ.

    Toxicol Appl Pharmacol. 2004 Aug 1;198(3):394-404. Review.PMID: 15276419 [PubMed - indexed for MEDLINE]Related articles

    7.

    Understanding arsenic carcinogenicity by the use of animal models.

    Wanibuchi H, Salim EI, Kinoshita A, Shen J, Wei M, Morimura K, Yoshida K, Kuroda K, Endo G, Fukushima S.

    Toxicol Appl Pharmacol. 2004 Aug 1;198(3):366-76. Review.PMID: 15276416 [PubMed - indexed for MEDLINE]Related articles

    8.

    Arsenic toxicity at low doses: epidemiological and mode of action considerations.

    Schoen A, Beck B, Sharma R, Dubé E.

    Toxicol Appl Pharmacol. 2004 Aug 1;198(3):253-67. Review.PMID: 15276404 [PubMed - indexed for MEDLINE]Related articles

    9.

    Arsenic in drinking water and bladder cancer mortality in the United States: an analysis based on 133 U.S. counties and 30 years of observation.

    Lamm SH, Engel A, Kruse MB, Feinleib M, Byrd DM, Lai S, Wilson R.

    J Occup Environ Med. 2004 Mar;46(3):298-306.PMID: 15091293 [PubMed - indexed for MEDLINE]Related articles

    10.

    Arsenic-induced enhancement of ultraviolet radiation carcinogenesis in mouse skin: a dose-response study.

    Burns FJ, Uddin AN, Wu F, Nádas A, Rossman TG.

    Environ Health Perspect. 2004 Apr;112(5):599-603.PMID: 15064167 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Arsenic toxicity, mutagenesis, and carcinogenesis--a health risk assessment and management approach.

    Tchounwou PB, Centeno JA, Patlolla AK.

    Mol Cell Biochem. 2004 Jan;255(1-2):47-55. Review.PMID: 14971645 [PubMed - indexed for MEDLINE]Related articles

    12.

    Case-control study of bladder cancer and exposure to arsenic in Argentina.

    Bates MN, Rey OA, Biggs ML, Hopenhayn C, Moore LE, Kalman D, Steinmaus C, Smith AH.

    Am J Epidemiol. 2004 Feb 15;159(4):381-9.PMID: 14769642 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Case-control study of bladder cancer and drinking water arsenic in the western United States.

    Steinmaus C, Yuan Y, Bates MN, Smith AH.

    Am J Epidemiol. 2003 Dec 15;158(12):1193-201.PMID: 14652304 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Health effects and risk assessment of arsenic.

    Abernathy CO, Thomas DJ, Calderon RL.

    J Nutr. 2003 May;133(5 Suppl 1):1536S-8S. Review.PMID: 12730460 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Assessment of cancer risk and environmental levels of arsenic in New Hampshire.

    Karagas MR, Stukel TA, Tosteson TD.

    Int J Hyg Environ Health. 2002 Mar;205(1-2):85-94.PMID: 12018020 [PubMed - indexed for MEDLINE]Related articles

    16.

    Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study.

    Karagas MR, Stukel TA, Morris JS, Tosteson TD, Weiss JE, Spencer SK, Greenberg ER.

    Am J Epidemiol. 2001 Mar 15;153(6):559-65.PMID: 11257063 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Lung cancer and arsenic concentrations in drinking water in Chile.

    Ferreccio C, González C, Milosavjlevic V, Marshall G, Sancha AM, Smith AH.

    Epidemiology. 2000 Nov;11(6):673-9. Erratum in: Epidemiology 2001 Mar;12(2):283. PMID: 11055628 [PubMed - indexed for MEDLINE]Related articles

    18.

    Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland.

    Kurttio P, Pukkala E, Kahelin H, Auvinen A, Pekkanen J.

    Environ Health Perspect. 1999 Sep;107(9):705-10.PMID: 10464069 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Drinking water arsenic in Utah: A cohort mortality study.

    Lewis DR, Southwick JW, Ouellet-Hellstrom R, Rench J, Calderon RL.

    Environ Health Perspect. 1999 May;107(5):359-65.PMID: 10210691 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Lung and kidney cancer mortality associated with arsenic in drinking water in Córdoba, Argentina.

    Hopenhayn-Rich C, Biggs ML, Smith AH.

    Int J Epidemiol. 1998 Aug;27(4):561-9.PMID: 9758107 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data